Literature DB >> 12774021

Elevated hepatocyte levels of the Forkhead box A2 (HNF-3beta) transcription factor cause postnatal steatosis and mitochondrial damage.

Douglas E Hughes1, Donna Beer Stolz, Songtao Yu, Yongjun Tan, Janardan K Reddy, Simon C Watkins, Anna Mae Diehl, Robert H Costa.   

Abstract

The Forkhead box (Fox) transcription factor Foxa2 (HNF-3beta) and related family members Foxa1 (HNF-3alpha) and Foxa3 (HNF-3gamma) act in concert with other hepatocyte nuclear factors (HNF) to coordinately regulate liver-specific gene expression. To circumvent the hepatic functional redundancy of the Foxa proteins, we used the T-77 transgenic (TG) mouse line in which the -3-kb transthyretin (TTR) promoter functioned to increase hepatocyte expression of the Foxa2 cDNA. Adult TG mice exhibited reduced hepatic glycogen and progressive liver injury, but maintained normal serum levels of glucose, insulin, and glucagon. In this study, we further characterized the postnatal liver defect in TTR-FoxA2 TG mice. The postnatal TG mice displayed significant reduction in serum glucose levels and in hepatocyte glycogen storage without increased serum levels of ketone bodies and free fatty acid suggesting that they are not undergoing a starvation response. We show that TG liver developed a substantial transient steatosis, which reached a maximum at postnatal day 5 and is associated with increased expression of hepatic genes involved in fatty acid and triglyceride synthesis, lipid beta-oxidation, and amino acid biosynthesis. Furthermore, transmission electron microscopy analysis of postnatal TG liver revealed extensive mitochondrial membrane damage, which is likely due to reactive oxygen species generated from lipid beta-oxidation. In conclusion, our model proposes that in response to reduction in hepatocyte glycogen storage, the TTR-Foxa2 TG mice survive by maintaining sufficient serum levels of glucose through gluconeogenesis using deaminated amino acids with dicarboxylate products of peroxisomal lipid beta-oxidation shuttled through the tricarboxylic acid cycle.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12774021     DOI: 10.1053/jhep.2003.50253

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  7 in total

1.  Genetic variations related to maternal whole blood mitochondrial DNA copy number: a genome-wide and candidate gene study.

Authors:  Tsegaselassie Workalemahu; Daniel A Enquobahrie; Mahlet G Tadesse; Karin Hevner; Bizu Gelaye; Sixto E Sanchez; Michelle A Williams
Journal:  J Matern Fetal Neonatal Med       Date:  2017-04-04

Review 2.  Inflammatory mediators of hepatic steatosis.

Authors:  Elizabeth Hijona; Lander Hijona; Juan I Arenas; Luis Bujanda
Journal:  Mediators Inflamm       Date:  2010-03-16       Impact factor: 4.711

3.  Three-dimensional analysis of abnormal ultrastructural alteration in mitochondria of hippocampus of APP/PSEN1 transgenic mouse.

Authors:  Ki Ju Choi; Mi Jeong Kim; A Reum Je; Sangmi Jun; Chulhyun Lee; Eunji Lee; Mijung Jo; Yang Hoon Huh; Hee-Seok Kweon
Journal:  J Biosci       Date:  2014-03       Impact factor: 1.826

4.  Cellular and molecular origin of circumpapillary dysgenesis of the pigment epithelium.

Authors:  Joaquin Tosi; Kerstin M Janisch; Nan-Kai Wang; J Mie Kasanuki; John T Flynn; Chyuan-Sheng Lin; Stephen H Tsang
Journal:  Ophthalmology       Date:  2009-05       Impact factor: 12.079

5.  Transcription factor binding site enrichment analysis predicts drivers of altered gene expression in nonalcoholic steatohepatitis.

Authors:  April D Lake; Alexandria L Chaput; Petr Novak; Nathan J Cherrington; Catharine L Smith
Journal:  Biochem Pharmacol       Date:  2016-11-09       Impact factor: 5.858

6.  Foxa1 reduces lipid accumulation in human hepatocytes and is down-regulated in nonalcoholic fatty liver.

Authors:  Marta Moya; Marta Benet; Carla Guzmán; Laia Tolosa; Carmelo García-Monzón; Eugenia Pareja; José Vicente Castell; Ramiro Jover
Journal:  PLoS One       Date:  2012-01-06       Impact factor: 3.240

7.  KIT is required for hepatic function during mouse post-natal development.

Authors:  Laetitia Magnol; Marie-Clémence Chevallier; Valérie Nalesso; Stéphanie Retif; Helmut Fuchs; Martina Klempt; Patricia Pereira; Michel Riottot; Sandra Andrzejewski; Bich-Thuy Doan; Jean-Jacques Panthier; Anne Puech; Jean-Claude Beloeil; Martin Hrabe de Angelis; Yann Hérault
Journal:  BMC Dev Biol       Date:  2007-07-05       Impact factor: 1.978

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.